美诺华：关于全资子公司获得枸橼酸莫沙必利片药品注册证书的公告

Core Viewpoint - Meihua announced that its wholly-owned subsidiary, Ningbo Meihua Tiankang Pharmaceutical Co., Ltd., has received the drug registration certificate for Mosapride Citrate Tablets from the National Medical Products Administration [2] Group 1 - The approval of the drug registration certificate marks a significant milestone for the company in expanding its product portfolio [2] - Mosapride Citrate is expected to enhance the company's competitive position in the pharmaceutical market [2]